We are monitoring the impact of COVID-19 on Europe Hormone Replacement Therapy Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 899
Share on
Share on

Europe Hormone Replacement Therapy Market Research Report - Segmented By Hormone Type, By Route Of Administration & By Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic & Rest of Europe) - Industry Analysis, Size, Share, Growth, Trends, & Forecasts (2019-2024)

Pulished: February, 2020
ID: 899
Pages: 133

Europe Hormone Replacement Therapy Market Size & Growth (2019 - 2024)

As per the research report, the size of the Europe Hormone Replacement Therapy Market Size is valued at USD 4.10 billion in 2019 and is predicted to become a USD 5.68 billion market by 2024, growing at a CAGR of 6.75% during the forecast period 2019-2024.

The key growth driver of the Europe hormone replacement therapy market is the increasing awareness about post-menopausal problems amongst women. The other noteworthy growth drivers are availability and development novel formulations, the presence of unmet medical needs that require the employment of hormone therapy. Hormone Replacement Therapy (HRT) in postmenopausal women is generally defined as treatment with estrogen or a combination of estrogen plus progestogen.

However, the risk of side effects, such as bleeding, bloating, mood changes, and nausea, breast tenderness or enlargement, headaches, risk of breast cancer, heart disease, and stroke is blocking the growth of the market. Along with this, the high cost of therapy is acting as a major hurdle. This is limiting its reach to middle-class consumers especially in the emerging nations of Central and Eastern Europe. Further, women with high susceptibility to coronary diseases, who are present in significant numbers in the European countries are kept away from taking hormone replacement therapy.

This research report segmented and sub-segmented into the following categories:

  • By Hormone Type: Estrogen Replacement Therapy, Growth Hormone Replacement Therapy, Thyroid replacement therapy, and others.
  • By Route of Administration: Oral, transdermal, parenteral, and other routes.
  • By Country: UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe

France provides ample opportunities for hormone replacement therapy industry and more than 50% of the women with menopause symptoms are reported to take hormone replacement therapy.

Key players operating in the Europe Hormone Replacement Therapy Market profiled in this report are NovartisAbbott LaboratoriesPfizerMylan LaboratoriesF. Hoffmann-La RocheMerck & CoAmgenEli LilyBayerNovo NordiskWyethHisamitsu Pharmaceutical Co. Inc

1.Introduction        

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods 

                1.4 General Study Assumptions                                

2. Research Methodology                 

                2.1 Introduction    

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                            

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                     

                                2.2.4 Expert Validation                  

                2.3 Analysis Design                                         

                2.4 Study Timeline

3. Overview            

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)            

                4.1 Market Drivers

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                               

5. Market Segmentation                    

                 5.1 By Hormone Type                                   

                                5.1.1 Estrogen Replacement Therapy                     

                                5.1.2 Growth Hormone Replacement Therapy                   

                                5.1.3 Thyroid Replacement Therapy                       

                                5.1.4 Others                      

                5.2 By Route of Administration                                 

                                5.2.1 Oral                            

                                5.2.2 Parenteral               

                                5.2.3 Transdermal                           

                                5.2.4 Others                      

6. Geographical Analysis                    

                                6.1 Introduction                              

                                6.2 U.K                

                                6.3 Spain                             

                                6.4 Germany                     

                                6.5 Italy                               

                                6.6 France                          

7. Pipeline Product Analysis             

                7.1 Overview          

                7.2 Pipeline Development Landscape          

                7.3 Molecular Targets in the Pipeline           

                7.4 Clinical Trials   

                                7.4.1 Failure Rate by Stage of Development, Indication, Molecule Type and Molecular Target                       

                                7.4.2 Clinical Trial Duration by Stage of Development, Indication, Molecule Type and Molecular Target                                  

                                7.4.3 Clinical Trial Size by Stage of Development, Indication, Molecule Type and Molecular Target.                               

8.Strategic Analysis              

                8.1 PESTLE analysis                                         

                                8.1.1 Political                     

                                8.1.2 Economic                 

                                8.1.3 Social                         

                                8.1.4 Technological                         

                                8.1.5 Legal                          

                                8.1.6 Environmental                      

                8.2 Porter’s Five analysis    

                                8.2.1 Bargaining Power of Suppliers                        

                                8.2.2 Bargaining Power of Consumers                    

                                8.2.3 Threat of New Entrants                     

                                8.2.4 Threat of Substitute Products and Services               

                                8.2.5 Competitive Rivalry within the Industry                      

9.Market Leaders' Analysis                

                9.1 Abbott Laboratories                               

                                9.1.1 Overview                

                                9.1.2 Product Analysis                   

                                9.1.3 Financial analysis                  

                                9.1.4 Recent Developments                       

                                9.1.5 SWOT analysis                       

                                9.1.6 Analyst View                          

                9.2 Novartis                                       

                9.3 Pfizer  

                9.4 Mylan Laboratories                                 

                9.5 Amgen                                         

                9.6 Merck & Co.                               

                9.7 Bayer  

                9.8 Eli Lily & Company                                  

                9.9 Novo Nordisk  

                9.10 Wyeth                                        

                9.11 F. Hoffmann-La Roche                                         

                9.12 Hisamitsu Pharmaceutical  Co. Inc.                                 

10.Competitive Landscape                

                10.1 Market share analysis

                10.2 Merger and Acquisition Analysis                                     

                10.3 Agreements, collaborations and Joint Ventures                                       

                10.4 New Product Launches                                       

11.Expert Opinions               

                11.1 Market Outlook                                     

                11.2 Investment Opportunities                                 

Appendix                 

                a) List of Tables                                

                b) List of Figures    

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe Hormone Replacement Therapy Market By Region, From 2019-2024 (USD Million)
  2. Europe Hormone Replacement Therapy Market By Hormone Type, From 2019-2024 (USD Million)
  3. Europe Estrogen Replacement Therapy Market By Region, From 2019-2024 (USD Million)
  4. Europe Growth Hormone Replacement Therapy Market By Region, From 2019-2024 (USD Million)
  5. Europe Thyroid Replacement Therapy Market By Region, From 2019-2024 (USD Million)
  6. Europe Other Hormone Therapies Market By Region, From 2019-2024 (USD Million)
  7. Europe Hormone Replacement Therapy Market By Route of Administration, From 2019-2024 (USD Million)
  8. United Kingdom Hormone Replacement Therapy Market By Hormone Type, From 2019-2024 (USD Million)
  9. United Kingdom Hormone Replacement Therapy Market By Route of Administration, From 2019-2024 (USD Million)
  10. Spain Hormone Replacement Therapy Market By Hormone Type, From 2019-2024 (USD Million)
  11. Spain Hormone Replacement Therapy Market By Route of Administration, From 2019-2024 (USD Million)
  12. Germany Hormone Replacement Therapy Market By Hormone Type, From 2019-2024 (USD Million)
  13. Germany Hormone Replacement Therapy Market By Route of Administration, From 2019-2024 (USD Million)
  14. France Hormone Replacement Therapy Market By Hormone Type, From 2019-2024 (USD Million)
  15. France Hormone Replacement Therapy Market By Route of Administration, From 2019-2024 (USD Million)
  16. Italy Hormone Replacement Therapy Market By Hormone Type, From 2019-2024 (USD Million)
  17. Italy Hormone Replacement Therapy Market By Route of Administration, From 2019-2024 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample